UC San Diego Health is the worldwide leader for pulmonary thromboendarterectomy (PTE) surgery, also known as pulmonary endarterectomy (PEA), to treat
chronic thromboembolic pulmonary hypertension (CTEPH).
Developed here at UC San Diego Health, PTE is a complex surgery that removes deadly chronic blood clots from major blood vessels in the lungs that cannot be treated with medication. Without treatment, these clots block off blood flow to the lungs, cause damaging vascular changes and pulmonary hypertension. This condition can lead to heart failure and death.
Read about our 4,000th PTE procedure and how it changes our patients' lives.
For individuals who are not candidates for PTE surgery, our team also offers
balloon pulmonary angioplasty and medical therapy.
Why Choose UC San Diego Health for PTE?
Misdiagnosis or failure to recognize CTEPH is common, leaving many people out of breath with a deadly, but treatable, disease. Our specialists are leaders in evaluating patients with chronic thromboembolic pulmonary hypertension.
Unmatched Volumes and Outcomes
UC San Diego Health boasts more successful PTEs than any other medical center and the lowest postoperative mortality rate worldwide. Patients with thromboembolic pulmonary hypertension who have not received appropriate diagnosis and treatment at other centers around the world are often treated successfully at our center.
Center of Excellence
Our PTE program is the first to be nationally designated as a
Center of Excellence by the American College of Chest Physicians.
We have the highest success rate in the world for pulmonary thromboendarterectomy – performing more PTEs than any other medical center (over 4,000).
Over the last several years the program has maintained a mortality rate of less than 1 percent, with very low morbidity and excellent hemodynamic outcomes. The procedure can reverse heart failure and is considered more effective than lung transplantation.
See if you're a candidate for PTE.